Does plasma therapy really help COVID-19 patients?

Experts weigh in whether convalescent plasma therapy is as dependable in fighting COVID-19 as celeb tweets claim

DGCI okays Itolizumab drug for restricted emergency use on COVID patients

Biocon, a domestic biopharmaceutical company, has been manufacturing and marketing the drug.

Virologist Shahid Jameel estimated that India gets about 100,000 to 200,000 confirmed cases of dengue each year.

According to a recent study, the device killed 99.8 per cent of the novel coronavirus, SARS-CoV-2, in a single pass through its filter

“We are aware of the article and are reviewing its contents with our technical experts,” WHO spokesman Tarik Jasarevic said

COVID-19 is one of the worst zoonotic disease, but it is not the first. Ebola, SARS, MERS, HIV, Lyme disease preceded it, UNEP Director said

Despite having the third largest number of coronavirus cases, India is an outsider when it comes to research on how the virus is transmitted

Scientists say there is evidence that coronavirus is airborne, ask WHO to revise its pandemic guideline

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

Another branch of the WHO-led trial is also looking at the potential effect of Gilead’s antiviral drug remdesivir on COVID-19